zm 336372 has been researched along with Cancer of Liver in 1 studies
N-(5-(3-dimethylaminobenzamido)-2-methylphenyl)-4-hydroxybenzamide: an inhibitor of c-Raf; activates Raf-1; structure in first source
| Excerpt | Relevance | Reference |
|---|---|---|
| "Hepatocellular carcinoma has been described to exhibit characteristics similar to that of neuroendocrine tumors (NETs)." | 1.35 | ZM336372, a Raf-1 activator, causes suppression of proliferation in a human hepatocellular carcinoma cell line. ( Chen, H; Deming, D; Geiger, P; Holen, K; Kunnimalaiyaan, M; Vaccaro, A, 2008) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Deming, D | 1 |
| Geiger, P | 1 |
| Chen, H | 1 |
| Vaccaro, A | 1 |
| Kunnimalaiyaan, M | 1 |
| Holen, K | 1 |
1 other study available for zm 336372 and Cancer of Liver
| Article | Year |
|---|---|
ZM336372, a Raf-1 activator, causes suppression of proliferation in a human hepatocellular carcinoma cell line.
Topics: Benzamides; Carcinoma, Hepatocellular; Cell Cycle; Cell Proliferation; Chromogranin A; Cyclin-Depend | 2008 |